1. Koyama S, Tomimatsu T, Kanagawa T, Kumasawa K, Tsutsui T, Kimura T. Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol. 2012. 87:15–21.
2. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood. 1994. 84:1851–1856.
3. Mizunuma H, Takahashi Y, Taguchi H, Arai A, Igarashi M, Morita K, et al. A new approach to idiopathic thrombocytopenic purpura during pregnancy by high-dose immunoglobulin G infusion. Am J Obstet Gynecol. 1984. 148:218–219.
4. Dan U, Barkai G, David B, Goldenberg M, Kukkia E, Mashiach S. Management of labor in patients with idiopathic thrombocytopenic purpura. Gynecol Obstet Invest. 1989. 27:193–196.
5. Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol. 1990. 163:1147–1150.
6. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv. 1993. 48:781–788.
7. Liebman HA, Pullarkat V. Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics. Hematology Am Soc Hematol Educ Program. 2011. 2011:384–390.